BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
Rhea-AI Summary
BillionToOne (NASDAQ:BLLN) announced that management will participate in the William Blair 46th Annual Growth Stock Conference. The company will present from 12:40pm to 1:10pm CT on Tuesday, June 2, 2026.
A live and archived webcast will be available on the Events & Presentations page of BillionToOne’s investor relations website.
Positive
- None.
Negative
- None.
News Market Reaction – BLLN
In the May 28 session, BLLN gained 7.45%, reflecting a notable positive market reaction. Argus tracked a peak move of +11.8% during that session. Our momentum scanner triggered 28 alerts that day, indicating elevated trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 06 | Earnings beat, guidance | Positive | +14.1% | Q1 2026 beat with revenue $108.4M and guidance raised to $450M–$465M. |
| May 01 | Product launch | Positive | -6.9% | Launch of Unity Confirm non‑invasive confirmation test with 16/16 concordance data. |
| Apr 15 | Earnings date notice | Neutral | -2.6% | Announcement of timing and webcast details for Q1 2026 earnings release. |
| Apr 02 | Leadership change | Neutral | -4.3% | Appointment of VP Medical Affairs & Clinical Development, Oncology, and CMO transition. |
| Mar 04 | Strong earnings, guidance | Positive | -10.7% | Very strong Q4/FY2025 results, raised 2026 outlook to $430M–$445M and positive GAAP outlook. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Strong fundamental updates often produced mixed or negative next-day moves, while major earnings beats with raised guidance have sometimes sold off despite positive news.
Over the last few months, BillionToOne has reported strong growth, with Q4 2025 revenue of $96.1M and FY2025 revenue of $305.1M, followed by Q1 2026 revenue of $108.4M and raised 2026 guidance to $450M–$465M. Product expansion continued with the Unity Confirm launch on May 1, 2026, and leadership changes supported the oncology portfolio. Despite these positives, shares often reacted negatively, so this conference-participation notice fits into a backdrop where fundamentals improved while price action was uneven.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced that Company management will participate in the William Blair 46th Annual Growth Stock Conference.
Management will present from 12:40pm to 1:10pm Central Time on Tuesday, June 2, 2026.
A live and archived webcast will be available on the “Events & Presentations” page of BillionToOne’s investor relations website at https://investors.billiontoone.com/news-events/events-presentations.
About BillionToOne
Headquartered in Menlo Park, California, BillionToOne is a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all. The company's patented Quantitative Counting Templates™ (QCT™) molecular counting platform is the only multiplex technology that can accurately count DNA molecules at the single-molecule level.
Investor Contact
ir@billiontoone.com
Media Contact
billiontoone@moxiegrouppr.com
